{"id":3167,"date":"2021-11-04T08:50:25","date_gmt":"2021-11-04T07:50:25","guid":{"rendered":"https:\/\/cendoc.h12o.es\/blog\/?p=3167"},"modified":"2021-11-04T08:50:25","modified_gmt":"2021-11-04T07:50:25","slug":"neoplasias-hematologicas-y-covid-19","status":"publish","type":"post","link":"https:\/\/cendoc.h12o.es\/blog\/2021\/11\/04\/neoplasias-hematologicas-y-covid-19\/","title":{"rendered":"Neoplasias hematol\u00f3gicas y COVID-19"},"content":{"rendered":"<p>Mar\u00eda Calbacho, del Servicio de Hematolog\u00eda del Hospital 12 de Octubre, participa como autora en este art\u00edculo publicado en la revista de acceso abierto <em>Journal of Hematology &amp; Oncology<img loading=\"lazy\" decoding=\"async\" class=\" wp-image-3871 alignright\" src=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=228&amp;h=155\" alt=\"logo12\" width=\"228\" height=\"155\" data-attachment-id=\"3871\" data-permalink=\"https:\/\/coronavirusbiblioh12o.wordpress.com\/2020\/05\/06\/7-mas-del-h12o\/logo12\/\" data-orig-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" data-orig-size=\"275,183\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"logo12\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" data-large-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" \/><\/em>: \u201c<a href=\"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-021-01177-0\" target=\"_blank\" rel=\"noopener\">COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)<\/a>\u201c.<\/p>\n<p>Los pacientes con neoplasias hematol\u00f3gicas tienen un alto riesgo de mortalidad a causa de la COVID-19. Un mayor conocimiento de los factores de riesgo puede mejorar el tratamiento de estos pacientes. El estudio se ha realizado con datos de 3.801 pacientes (marzo-diciembre 2020) con neoplasias hematol\u00f3gicas y confirmaci\u00f3n de COVID-19 por laboratorio.<\/p>\n<p>Se observ\u00f3 COVID-19 grave en el 64% de los casos. Un 73% de los pacientes fue hospitalizado, de los cuales un 18% ingres\u00f3 en UCI. Falleci\u00f3 el 31% de los pacientes, siendo la COVID-19 la primera causa de muerta seguida de las neoplasias hematol\u00f3gicas. La mortalidad m\u00e1s alta se observ\u00f3 en leucemia mieloide aguda. La tasa de mortalidad descendi\u00f3 entre la primera y la segunda olas. En el an\u00e1lisis multivariable, la edad, la neoplasia maligna activa, la enfermedad card\u00edaca cr\u00f3nica, la patolog\u00eda hep\u00e1tica, la insuficiencia renal, los antecedentes de tabaquismo y la estancia en UCI se correlacionaron con la mortalidad.<\/p>\n<p><em>Equipo Biblioteca H12O<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mar\u00eda Calbacho, del Servicio de Hematolog\u00eda del Hospital 12 de Octubre, participa como autora en este art\u00edculo publicado en la revista de acceso abierto Journal of Hematology &amp; Oncology: \u201cCOVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)\u201c. Los pacientes con neoplasias hematol\u00f3gicas tienen un \u2026<\/p>\n<p class=\"continue-reading-button\"> <a class=\"continue-reading-link\" href=\"https:\/\/cendoc.h12o.es\/blog\/2021\/11\/04\/neoplasias-hematologicas-y-covid-19\/\">Continuar leyendo<i class=\"crycon-right-dir\"><\/i><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[4,64,46],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3G9TJ-P5","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/3167"}],"collection":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/comments?post=3167"}],"version-history":[{"count":1,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/3167\/revisions"}],"predecessor-version":[{"id":3168,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/3167\/revisions\/3168"}],"wp:attachment":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/media?parent=3167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/categories?post=3167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/tags?post=3167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}